1. Home
  2. TLSA vs SANG Comparison

TLSA vs SANG Comparison

Compare TLSA & SANG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TLSA
  • SANG
  • Stock Information
  • Founded
  • TLSA 2013
  • SANG 1984
  • Country
  • TLSA United Kingdom
  • SANG Canada
  • Employees
  • TLSA N/A
  • SANG N/A
  • Industry
  • TLSA Biotechnology: Pharmaceutical Preparations
  • SANG Computer Software: Programming Data Processing
  • Sector
  • TLSA Health Care
  • SANG Technology
  • Exchange
  • TLSA Nasdaq
  • SANG Nasdaq
  • Market Cap
  • TLSA 175.3M
  • SANG 189.6M
  • IPO Year
  • TLSA 2000
  • SANG 2021
  • Fundamental
  • Price
  • TLSA $1.55
  • SANG $5.68
  • Analyst Decision
  • TLSA
  • SANG
  • Analyst Count
  • TLSA 0
  • SANG 0
  • Target Price
  • TLSA N/A
  • SANG N/A
  • AVG Volume (30 Days)
  • TLSA 282.4K
  • SANG 5.5K
  • Earning Date
  • TLSA 07-01-2025
  • SANG 05-08-2025
  • Dividend Yield
  • TLSA N/A
  • SANG N/A
  • EPS Growth
  • TLSA N/A
  • SANG N/A
  • EPS
  • TLSA N/A
  • SANG N/A
  • Revenue
  • TLSA N/A
  • SANG $238,264,000.00
  • Revenue This Year
  • TLSA N/A
  • SANG N/A
  • Revenue Next Year
  • TLSA N/A
  • SANG $2.91
  • P/E Ratio
  • TLSA N/A
  • SANG N/A
  • Revenue Growth
  • TLSA N/A
  • SANG N/A
  • 52 Week Low
  • TLSA $0.63
  • SANG $4.08
  • 52 Week High
  • TLSA $1.91
  • SANG $7.99
  • Technical
  • Relative Strength Index (RSI)
  • TLSA 59.97
  • SANG 50.84
  • Support Level
  • TLSA $1.35
  • SANG $5.67
  • Resistance Level
  • TLSA $1.67
  • SANG $5.84
  • Average True Range (ATR)
  • TLSA 0.10
  • SANG 0.16
  • MACD
  • TLSA 0.02
  • SANG -0.01
  • Stochastic Oscillator
  • TLSA 80.88
  • SANG 52.00

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

About SANG Sangoma Technologies Corporation

Sangoma Technologies Corp is a provider of hardware and software components that enable or enhance Internet Protocol Communications Systems for both telecom and datacom applications. It is engaged in the development, manufacturing, distribution, and support of voice and data connectivity components for software-based communication applications. Its product includes data and telecom boards for media and signal processing, as well as gateway appliances and software. The Company sells into two geographic centers: USA and Other countries. Key revenue is generated from USA.

Share on Social Networks: